Signia Therapeutics is an innovative French start-up company.
Signia Therapeutics has raised $1.9M in total funding. The most recent round was Grant. The last funding was announced in January 2022.
Signia Therapeutics's investors include Bpifrance, EISMEA, Neovacs.
Signia Therapeutics is headquartered in Lyon, France.
Signia Therapeutics is an innovative French start-up company.
Signia Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Signia Therapeutics — Funding & Investors." VCBacked, January 4, 2022, https://www.vcbacked.co/company/signia-therapeutics. Accessed September 29, 2026.
VCBacked. (2022). Signia Therapeutics — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/signia-therapeutics
{{cite web |title=Signia Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/signia-therapeutics |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated